Inotiv provides a fully integrated non-GLP bioanalytical drug discovery solution customized to your company’s project goals. We offer pharmacological and toxicological assessment across multiple therapeutic areas and species to ensure the right studies are performed at the right time.

Our discovery solution supports your therapeutic candidates with in vitro / in vivo DMPK, biology, PK, PD, and toxicology using high-throughput technology platforms. As your partner, you have access to unique insights that rapidly advance your discovery efforts for small molecule and biotherapeutic development.

Inotiv Frost and Sullivan 2022 AwardAs a proud winner of the Frost & Sullivan 2022 North American Bioanalytical Testing Services Customer Value Leadership Award, we are committed to delivering more attention, more insight, and a superlative client experience to help you advance to your next milestone.

To talk to an expert about our Nonregulated Bioanalytical Services, please click here.

List of Assays

Nonregulated discovery bioanalysis chart


Small Molecule Development

We offer extensive platform suites available for small molecule bioanalysis, comprised of industry-leading instrumentation to support global studies with rapid, precise, and reproducible results. Discovery bioanalysis platforms include:

  • Liquid Chromatography, Tandem Mass Spectrometry
    • AB SCIEX™ Platform (4000, 5500, 6500, 7500)
  • Contemporary Method Development
    • Ballistic gradients, UPLC-ready columns
  • Tiered Stage-Appropriate Rigor for Bioanalysis
    • Level 1 for screening; Level 2 for non-GLP IND-enabling
  • High Resolution Mass Spectrometry Technology
    • Thermo Exploris™, LTQ Orbitrap, and Agilent 6550 Q-TOF
  • TECAN – Liquid Handling and Assay Automation
  • HT Tissue Cryo-Homogenization and VAMS Processing
  • Watson LIMS™ (Accessioning/PK Analysis) – Discovery Stage

To learn more about our Small Molecule Nonregulated Discovery Bioanalytical service click here.

Biotherapeutic Development

Our experienced non-GLP bioanalytical team utilize state-of-the-art molecular and cell-based platforms to rapidly develop and validate methods to support the biomarker discovery, gene therapy and biotherapeutic programs. Our capabilities include:

  • DNA/RNA Isolation
  • RT-PCR, qPCR
  • Flow Cytometry
  • Cytokine Panels
  • Protein Expression Analysis
  • ELISA (single and multiplex)
  • Transporter Assays: Solution Carrier (SLC) and ATP-Binding Cassettes (ABC)
  • Hepatitis B Virus (HBV) Titers

To learn more about our Biotherapeutic services for Nonregulated Discovery Bioanalytical click here.

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now